Euroapi Future Growth
Future criteria checks 0/6
Euroapi's revenue is forecast to decline at 0.2% per annum while its annual earnings are expected to grow at 73.1% per year. EPS is expected to grow by 75.8% per annum. Return on equity is forecast to be -1% in 3 years.
Key information
73.1%
Earnings growth rate
75.8%
EPS growth rate
| Pharmaceuticals earnings growth | 16.4% |
| Revenue growth rate | -0.2% |
| Future return on equity | -1.0% |
| Analyst coverage | Low |
| Last updated | 04 Oct 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 929 | -31 | 13 | 86 | 5 |
| 12/31/2025 | 935 | -42 | -2 | 92 | 5 |
| 12/31/2024 | 918 | -86 | 83 | 168 | 5 |
| 6/30/2024 | 971 | -287 | -39 | 115 | N/A |
| 3/31/2024 | 995 | -238 | -100 | 60 | N/A |
| 12/31/2023 | 1,019 | -190 | -161 | 5 | N/A |
| 9/30/2023 | 1,006 | -79 | -133 | 4 | N/A |
| 6/30/2023 | 994 | 31 | -105 | 3 | N/A |
| 3/31/2023 | 987 | 8 | -87 | 24 | N/A |
| 12/31/2022 | 981 | -15 | -69 | 45 | N/A |
| 9/30/2022 | 962 | -3 | -99 | 46 | N/A |
| 6/30/2022 | 944 | 10 | -129 | 47 | N/A |
| 3/31/2022 | 918 | 1 | -96 | 59 | N/A |
| 12/31/2021 | 893 | -8 | -64 | 72 | N/A |
| 12/31/2020 | 945 | -6 | 8 | 97 | N/A |
| 12/31/2019 | 916 | 3 | -47 | 35 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0EAP is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 0EAP is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 0EAP is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 0EAP's revenue is expected to decline over the next 3 years (-0.2% per year).
High Growth Revenue: 0EAP's revenue is forecast to decline over the next 3 years (-0.2% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 0EAP is forecast to be unprofitable in 3 years.